FDA User Fee Reauthorization Passes House, Awaits Conference
This article was originally published in The Gray Sheet
Executive Summary
The House passed broad-based FDA legislation July 11 that includes a package to reauthorize the medical device user fee program
You may also be interested in...
Congress Approves FDA Reform/User Fee Bill In The Nick Of Time
Congress gave final approval last week to a massive FDA bill that renews device and drug user fees for five years and strengthens product safety programs
Congress Approves FDA Reform/User Fee Bill In The Nick Of Time
Congress gave final approval last week to a massive FDA bill that renews device and drug user fees for five years and strengthens product safety programs
Congress Down To The Wire On FDA User Fee Reauthorization, SCHIP
FDA reform legislation reauthorizing device and drug user fees may not be finalized by Congress in time to avoid agency layoffs